Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)
NCT05646303 · Clairvoyant Therapeutics
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
Reduction in the number of Heavy Drinking Days
Measured over 8 weeks
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
12 study sites
| Facility | City | Region | Country |
|---|---|---|---|
| Sabi Mind | Calgary | Alberta | Canada |
| Okanagan Clinical Trials | Kelowna | British Columbia | Canada |
| Centre for Neurology Studies | Surrey | British Columbia | Canada |
| University of British Columbia, Department of Psychiatry, BRAIN Lab | Vancouver | British Columbia | Canada |
| Centricity Research | Halifax | Nova Scotia | Canada |
| MacAnxiety Research Centre | Hamilton | Ontario | Canada |
| Department of Psychiatry, Queen's University | Kingston | Ontario | Canada |
| Centre for Addiction and Mental Health | Toronto | Ontario | Canada |
| Research Center Oxidi Oy / Addiktum Oy | Helsinki | — | Finland |
| A-Klinikka | Kouvola | — | Finland |
| Mentacare Oy | Oulu | — | Finland |
| Addiktum Oy | Turku | — | Finland |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT05646303 on ClinicalTrials.gov →
Last updated in the registry 2024-08-15. Registry records change; this page reflects the data build of 2026-08-25.
Related
Where this trial sits
Substance
Indication